Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
In April 2024 a €10 million top-up for the MSCA4Ukraine initiative was announced by the European Commission (Horizon Europe work programme 2023-2025 MSCA). For the second call it is expected approximately 50 fellowships (with a minimum duration of 6 months and a maximum duration of 24 months) will be awarded.
For the second call an Information for Applicants webpage with several call documents, including the application templates, a FAQ, and a webinar recording have been made available on the Scholars at Risk Europe website.
Applications must be submitted by prospective host organisations on behalf of displaced researcher(s) from Ukraine (candidate(s)). Host organisations can be academic or non-academic organisations in any EU Member State or Horizon Europe Associated Country. Organisations located in Ukraine are not eligible to apply as primary host organisations but can host researchers during a secondment arrangement.
Candidates: either postdoctoral researchers or researchers who, on or after 24 February 2022, were enrolled as doctoral candidates at a higher educational institution in Ukraine, and who have been displaced from Ukraine on or after 24 February 2022 are eligible to be nominated. Only one proposal per individual researcher can be submitted. Current and former MSCA4Ukraine fellows are not eligible to be nominated.
The submission portal will be opened on 5 August and closed on 5 September 23:59h CEST. The access link will be made available on the Information for Applicants webpage.
The evaluation and selection process will take place between October 2024 and February 2025 and the expected start of the fellowships between April and June 2025. Between May and November 2025 applicants from the reserve list will be offered funding should any awarded fellowship offers be declined, until all available funds have been disbursed.
All information related to the second (and previous) call for applications to MSCA4Ukraine is available on the Scholars at Risk Europe website.
2024-10-24
|
3 weeks ago |
Survey on the added value of MSCA PhDs |
2024-10-04
|
1 month ago |
Joint statement ‘We need much more MSCA!’ published |
2024-09-27
|
1 month ago |
Number of submitted proposals MSCA Cofund 2024 call |
2024-09-20
|
1 month ago |
Marie Skłodowska-Curie Actions’ Newsletter latest edition |
2024-09-12
|
2 months ago |
Number of submitted proposals - MSCA Postdoctoral Fellowships 2024 call – deadline 11... |
2024-09-02
|
2 months ago |
Horizon Europe Impact training session and Proposal workshop coming up this Autumn |
2024-08-23
|
2 months ago |
Apply now to attend the 74th Lindau meeting on chemistry |
2024-07-15
|
4 months ago |
Survey to collect best practice examples on supervision in MSCA |
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI, data & cloud
The European Commission’s Artificial Intelligence (AI) Office has launched a targeted stakeholders consultation process on the future guidelines on the AI system definition and the implementation of AI practices that pose unacceptable risks under the AI Act. The guidelines will help national competent authorities as well as providers and dep... read more
Digital, Industry & Space AI, data & cloud
The European Commission has published the first draft of the General-Purpose Artificial Intelligence (AI) Code of Practice. The rules governing general-purpose AI models under the AI Act will come into application in August 2025. The Code of Practice aims to facilitate the proper implementation of these rules and will play a crucial role in guidin... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.